Complexes of DNA vaccines with cationic, antigenic peptides are potent, polyvalent CD8(+) T-cell-stimulating immunogens
- PMID: 16988454
- DOI: 10.1385/1-59745-168-1:159
Complexes of DNA vaccines with cationic, antigenic peptides are potent, polyvalent CD8(+) T-cell-stimulating immunogens
Abstract
A priority in current vaccine research is the development of multivalent vaccines that support the efficient priming of long-lasting CD8(+) T-cell immunity. We developed a novel vaccination strategy that used synthetic, cationic (positively charged), and antigenic peptides complexed to negatively charged nucleic acids: antigenic, major histocompatibility complex-class I-binding epitopes fused with a cationic sequence derived from the HIV tat protein (tat50-57: KKRRQRRR) were mixed with nucleic acids (e.g., CpG-containing oligonucleotides) to quantitatively form peptide/nucleic acid complexes. The injection of these complexes efficiently primed long-lasting, specific CD8(+) T-cell immunity of high magnitude. This chapter describes a novel strategy to codeliver complexes of cationic/antigenic peptides bound to antigen-encoding plasmid DNA vaccines in a way that enhances the immunogenicity of both components for T cells.
Similar articles
-
Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.Hepatology. 2004 Aug;40(2):300-9. doi: 10.1002/hep.20330. Hepatology. 2004. PMID: 15368434
-
Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines.J Mol Med (Berl). 2004 Feb;82(2):144-52. doi: 10.1007/s00109-003-0502-3. Epub 2003 Dec 2. J Mol Med (Berl). 2004. PMID: 14652667
-
Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate Toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T cells.J Immunol. 2003 Nov 15;171(10):5198-207. doi: 10.4049/jimmunol.171.10.5198. J Immunol. 2003. PMID: 14607920
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
DNA fusion gene vaccines.Curr Opin Mol Ther. 2010 Feb;12(1):47-54. Curr Opin Mol Ther. 2010. PMID: 20140816 Review.
Cited by
-
Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.J Neuroimmunol. 2008 Nov 15;204(1-2):92-100. doi: 10.1016/j.jneuroim.2008.07.005. J Neuroimmunol. 2008. PMID: 18706703 Free PMC article.
-
DNA immunization as an efficient strategy for vaccination.Avicenna J Med Biotechnol. 2009 Jul;1(2):71-88. Avicenna J Med Biotechnol. 2009. PMID: 23407787 Free PMC article.
-
Improvement of different vaccine delivery systems for cancer therapy.Mol Cancer. 2011 Jan 7;10:3. doi: 10.1186/1476-4598-10-3. Mol Cancer. 2011. PMID: 21211062 Free PMC article. Review.
-
Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3.Clin Vaccine Immunol. 2015 Jan;22(1):79-90. doi: 10.1128/CVI.00476-14. Epub 2014 Nov 5. Clin Vaccine Immunol. 2015. PMID: 25378352 Free PMC article.
-
Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research.BMC Immunol. 2008 Mar 16;9:8. doi: 10.1186/1471-2172-9-8. BMC Immunol. 2008. PMID: 18366636 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials